Localized scleroderma and related comorbidities: a single-centre cohort study
At our centre, patients with morphoea often require systemic immunomodulatory treatment or phototherapy. The incidence of the generalized subtype and the occurrence of concomitant autoimmune diseases, particularly thyroid autoimmune diseases, is relatively high. No evidence of an increased risk of malignancy was found in these patients.
Authors
- Johanna Paltta (ORCID: https://orcid.org/0000-0002-1747-2421)
- Tiia Rissanen (ORCID: https://orcid.org/0009-0002-6701-8523)
- Veli‐Matti Kähäri (ORCID: https://orcid.org/0000-0003-2421-9368)
- S. Kortelainen (ORCID: https://orcid.org/0000-0002-4681-4013)
- Laura Pirilä (ORCID: https://orcid.org/0000-0002-4276-7344)
- Niina Hieta (ORCID: https://orcid.org/0000-0001-6449-3076)
Institutions
- University of Turku (FI)
- Turku University Hospital (FI)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1093/bjd/ljaf419
- Citations
- 1
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Turun Yliopisto
- Sigrid Juséliuksen Säätiö
- Turun Yliopistollinen Keskussairaala